Novartis’ iptacopan shows promise in Phase III trial for IgA nephropathy
Novartis (SIX:NOVN) announced on Monday that its investigational drug, iptacopan, demonstrated significant proteinuria reduction in a Phase III trial for…
European stocks start fourth quarter with gains; focus on PMI data
(Reuters) – European stocks started the final quarter of 2023 with modest gains on Monday, as the U.S. avoided a…
Tesla can’t avoid EU probe; Nio cries fake news: This week in EVs
Nio denies fundraising efforts Chinese EV builder NIO (HK:9866) (NYSE:NIO) saw its shares dented amid reports of a potential $3…
Top 5 things to watch in markets in the week ahead
With an eleventh-hour deal reached to avert a U.S. government shutdown investors will be focusing on U.S. jobs data and…
Coinbase secures major payment institution license in Singapore
Crypto exchange Coinbase (NASDAQ:COIN), based in San Francisco, has solidified its presence in Southeast Asia by obtaining a Major Payment…
S&P 500 Set for Decline Amid Rising Interest Rates and Economic Pressures
The S&P 500 is poised for a downturn due to a combination of high interest rates and various economic pressures,…
Spotify downgraded, ‘darkest days of this downturn are ahead’: 4 big analyst cuts
Spotify slashed to Neutral Monness, Crespi, Hardt downgraded Spotify Technology (NYSE:SPOT) to Neutral from Buy. Given the significant stock outperformance…
Underlying US inflation pressures subside in August
(Reuters) – Underlying U.S. inflation pressures moderated in August, with the annual rise in prices excluding food and energy falling…
FX clampdown boosts Pakistani rupee 6.1% to become September’s top currency
(Reuters) – Pakistan’s rupee has gained 6.1% against the dollar so far in September, following an official clampdown on illegal…
Credit Suisse Anticipates Q3 Loss Following UBS Takeover
Credit Suisse, now a part of UBS, expects to report a third-quarter loss of approximately $1.6 billion due to the…